|
|
|
|
| LEADER |
01000cam a2200265 4500 |
| 001 |
1618658530 |
| 003 |
DE-627 |
| 005 |
20230427210055.0 |
| 007 |
tu |
| 008 |
160222s2015 xxk||||| 00| ||eng c |
| 020 |
|
|
|a 9780128000168
|9 978-0-12-800016-8
|
| 020 |
|
|
|a 0128000163
|9 0-12-800016-3
|
| 035 |
|
|
|a (DE-627)1618658530
|
| 035 |
|
|
|a (DE-576)455742138
|
| 035 |
|
|
|a (DE-599)BSZ455742138
|
| 035 |
|
|
|a (OCoLC)879582230
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XA-GB
|
| 050 |
|
0 |
|a RJ504.7
|
| 245 |
1 |
4 |
|a The science and ethics of antipsychotic use in children
|c edited by Nina Di Pietro and Judy Illes
|
| 264 |
|
1 |
|a Amsterdsam
|a Boston
|a Heidelberg
|a London
|a New York
|a Oxford
|a Paris
|a San Diego
|a San Francisco
|a Singapore
|a Sydney
|a Tokyo
|b Elsevier, AP
|c [2015]
|
| 300 |
|
|
|a XXII, 205 Seiten
|b Illustrationen
|c 24 cm
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Includes bibliographical references and index
|
| 505 |
8 |
0 |
|t A brief history of the science and ethics of antipsychotics of off-label prescribing
|
| 505 |
8 |
0 |
|t Pharmacoepidemiology of antipsychotic use in Canadian children and adolescents
|
| 505 |
8 |
0 |
|t Do we know if they work and if they are safe : second-generation antipsychotics for treatment of autism spectrum disorders and disruptive behavior disorders in children and adolescents
|
| 505 |
8 |
0 |
|t Ensuring the safety of children treated with second-generation antipsychotics
|
| 505 |
8 |
0 |
|t Pediatric clinical trial activity for antipsychotics and the sharing of results : a complex ethical landscape
|
| 505 |
8 |
0 |
|t Pathways to overmedication and polypharmacy : case examples from adolescents with fetal alcohol spectrum disorders
|
| 505 |
8 |
0 |
|t Implementing change in prescribing practices
|
| 505 |
8 |
0 |
|t Canadian initiatives and recommendations : safeguarding the health of children and youth receiving off-label treatment with antipsychotics
|
| 650 |
|
0 |
|a Antipsychotic Agents
|x therapeutic use
|
| 650 |
|
0 |
|a Child
|
| 650 |
|
0 |
|a Adolescent
|
| 650 |
|
0 |
|a Antipsychotic Agents
|x adverse effects
|
| 650 |
|
0 |
|a Off-Label Use
|x ethics
|
| 650 |
|
0 |
|a Ethics, Medical
|
| 650 |
|
0 |
|a Age Factors
|
| 650 |
|
0 |
|a Pediatric psychopharmacology
|
| 650 |
|
0 |
|a Child mental health
|
| 650 |
|
0 |
|a Antipsychotic drugs
|
| 650 |
|
0 |
|a Antipsychotic drugs
|
| 650 |
|
0 |
|a Child mental health
|
| 650 |
|
0 |
|a Pediatric psychopharmacology
|
| 650 |
|
2 |
|a Canada
|
| 700 |
1 |
|
|a Di Pietro, Nina
|e herausgeberin
|0 (DE-627)1525740776
|0 (DE-576)455740771
|4 edt
|
| 700 |
1 |
|
|a Illes, Judy
|e herausgeberin
|0 (DE-588)136539130
|0 (DE-627)584498462
|0 (DE-576)301071748
|4 edt
|
| 912 |
|
|
|a GBV_ILN_2004
|
| 912 |
|
|
|a ISIL_DE-25-38
|
| 912 |
|
|
|a SYSFLAG_1
|
| 912 |
|
|
|a GBV_KXP
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 951 |
|
|
|a BO
|
| 980 |
|
|
|2 2004
|1 01
|x DE-25-38
|b 3218269377
|c 00
|f --%%--
|d Frei 38: Lc 6d/197
|e p
|j --%%--
|y l01
|z 22-02-16
|
| 998 |
|
|
|2 2004
|1 01
|x DE-25-38
|0 1608
|
